New data from two studies on adjuvant radiation and thalidomide post-surgery

Biochemical recurrence after first-line treatment for localized prostate cancer affects some 30 to 40 percent of prostate cancer patients. Two articles to be published in the March 2009 issue of The Journal of Urology provide interesting new data on the treatment of men who have either failed first-line surgical treatment or are at high risk for such failure. … READ MORE …